Table 1:
Patients Demographics and Baseline Characteristics, CEASAR study, 2011-2012
| Patient Characteristics | Subjects (N=2563) |
|---|---|
| Age at diagnosis (Median, IQR) | 64 (58,69) |
| Race | |
| White | 74% (1884) |
| Black | 14% ( 359) |
| Hispanic | 7% ( 187) |
| Asian | 3% ( 80) |
| Other | 1% ( 37) |
| Education | |
| <High school | 10% (250) |
| High school graduate | 21% (500) |
| Some college | 22% (533) |
| College graduate | 23% (562) |
| Graduate or professional school | 24% (588) |
| Marital status | |
| Not married | 20% ( 474) |
| Married | 80% (1953) |
| TIBI Comorbidity score | |
| 0-2 | 28% ( 690) |
| 3-4 | 42% (1024) |
| >= 5 | 30% ( 731) |
| D’Amico prostate cancer risk | |
| Low risk | 45% (1151) |
| Intermediate risk | 39% ( 988) |
| High risk | 16% ( 418) |
| Prostate specific antigen, ng/mL | |
| [0,4] | 21% ( 529) |
| (4,10] | 66% (1693) |
| (10,20] | 10% ( 257) |
| (20,50] | 3% ( 84) |
| Clinical stage | |
| T1 | 76% (1943) |
| T2 | 24% ( 609) |
| Biopsy Gleason score | |
| 6 or less | 52% (1331) |
| 3 + 4 | 28% ( 707) |
| 4 + 3 | 10% ( 264) |
| 8,9,10 | 10% ( 253) |
| Any hormone therapy in the first year | |
| No | 86% (2157) |
| Yes | 14% ( 346) |
| Accrual site | |
| Louisiana | 28% (725) |
| Utah | 8% (206) |
| Atlanta | 12% (309) |
| Los Angeles County, CA | 29% (731) |
| New Jersey | 16% (411) |
| CaPSURE | 7% (181) |
Abbreviations: CaPSURE- Cancer of the Prostate Strategic Urologic Research Endeavor